Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of Natural Human Interferon Alpha Administered Oromucosally in the Treatment of Oral Warts in HIV-seropositive Subjects Receiving Combination Anti-retroviral Therapy: A Phase 2 Clinical Trial.

Trial Profile

Evaluation of Natural Human Interferon Alpha Administered Oromucosally in the Treatment of Oral Warts in HIV-seropositive Subjects Receiving Combination Anti-retroviral Therapy: A Phase 2 Clinical Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2011

At a glance

  • Drugs Interferon alpha (Primary)
  • Indications Warts
  • Focus Therapeutic Use
  • Sponsors Amarillo Biosciences
  • Most Recent Events

    • 13 Oct 2009 Actual patient number (59) added as reported by ClinicalTrials.gov.
    • 13 Oct 2009 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
    • 13 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top